Bruker (BRKR) Net Equity Issued and Repurchased (2010 - 2025)

Bruker's Net Equity Issued and Repurchased history runs 16 years deep, the most recent figure standing at $665.6 million for Q4 2025.

• Quarterly Net Equity Issued and Repurchased rose 20700.0% year-over-year to $665.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $669.7 million (up 63.74% YoY) and the FY2025 annual result came in at $669.7 million, up 63.74% from the prior year.
• Net Equity Issued and Repurchased was $665.6 million for Q4 2025 at Bruker, up from -$1.2 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $665.6 million in Q4 2025 and bottomed at -$2.8 million in Q3 2024.
• A 5-year average of $54.9 million and a median of $2.0 million in 2022 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased plunged 240.0% — and 2025, when it surged 20700.0%.
• Bruker's Net Equity Issued and Repurchased stood at $1.1 million in 2021, then soared by 81.82% to $2.0 million in 2022, then surged by 135.0% to $4.7 million in 2023, then plunged by 31.91% to $3.2 million in 2024, then jumped by 20700.0% to $665.6 million in 2025.
• Business Quant data shows BRKR's Net Equity Issued and Repurchased at $665.6 million in Q4 2025, -$1.2 million in Q3 2025, and $4.9 million in Q2 2025.